1. Isoproterenol-induced Upregulation of HPSE Accelerates Triple-negative Breast Cancer Cell Proliferation and Migration through Enhancing the Transcriptional Activity of HIF-1α
   Guoqin Jiang et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
2. The prognostic value of absolute lymphocyte count and neutrophil‐to‐lymphocyte ratio for patients with metastatic breast cancer: a systematic review and meta‐analysis
   Bulin Sang et al, 2024, Frontiers in Oncology CrossRef
3. Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer
   Wen-Jing Yang et al, 2021, Aging CrossRef
4. Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies
   Shinjit Mani et al, 2022, BioNanoScience CrossRef
5. Potential roles of heparanase in cancer therapy: Current trends and future direction
   Yiyuan Yang et al, 2023, Journal of Cellular Physiology CrossRef
6. Impact of Adjuvant Treatment on Heparanase Concentration in Invasive, Unilateral Breast Cancer Patients: Results of a Prospective Single-Centre Cohort Study
   Barbara Ruszkowska-Ciastek et al, 2021, Journal of Clinical Medicine CrossRef
7. Extracellular vesicles released during hypoxia transport heparanase and enhance macrophage migration, endothelial tube formation and cancer cell stemness
   Kaushlendra Tripathi et al, 2023, Proteoglycan Research CrossRef
8. Role of heparanase in pulmonary hypertension
   Lin-Jun Wang et al, 2023, Frontiers in Pharmacology CrossRef